Proton Pump Inhibitors vs Histamine-2 Receptor Blockers for Stress Ulcer Prophylaxis in Critically Ill Patients: Issues of Interpretability in Pragmatic Trials

JAMA. 2020 Feb 18;323(7):611-613. doi: 10.1001/jama.2019.22436.
No abstract available

Publication types

  • Research Support, N.I.H., Extramural
  • Comment

MeSH terms

  • Critical Illness*
  • Histamine
  • Histamine H2 Antagonists
  • Hospital Mortality
  • Humans
  • Intensive Care Units
  • Proton Pump Inhibitors*
  • Respiration, Artificial
  • Ulcer

Substances

  • Histamine H2 Antagonists
  • Proton Pump Inhibitors
  • Histamine